modification selection and
play

Modification, Selection and Production of Cyclic Peptides iGEM 2011 - PowerPoint PPT Presentation

Modification, Selection and Production of Cyclic Peptides iGEM 2011 World Championship Jamboree at MIT in Boston Sunday, 6th November 2011 Outline Introduction Laboratory Outreach & Xtras 2 Potential of Cyclic Peptides every year,


  1. Modification, Selection and Production of Cyclic Peptides iGEM 2011 World Championship Jamboree at MIT in Boston Sunday, 6th November 2011

  2. Outline Introduction Laboratory Outreach & Xtras 2

  3. Potential of Cyclic Peptides • every year, millions of people are infected with deseases related to protease activity • cyclic peptides • stable • unique potential • use as therapeutic agent 3

  4. Microviridin Family • cyclization over side chain residues – no cysteins or any backbone structure involved • cyclic peptide with two ester and one amide bond 4

  5. The Project Microcystis aeruginosa mdn cluster Heterologous Expression in E. coli Library Generation Selection System Optimized Protease Inhibitor

  6. Modularization of the Cluster mdnA mdnB mdnC mdnD mdnE mdnA mdnB mdnC mdnD mdnE BBa_K627001 BBa_K627002 BBa_K627003 BBa_K627004 BBa_K627005 ligase acetyltransferase ABC transporter ligase • 6.5 kbp cluster with 5 important elements: • mdnA pro-peptide sequence • 4 different enzymes for processing of the pro peptide 6

  7. Characterization mdnA mdnB mdnC mdnD mdnE 700000 YGGTFKYPSDWEDY 600000 1734.12 Da 500000 mAU at 210 nm 400000 300000 200000 +22 Da +38 Da 100000 -766 Da -368 Da 0 900 1200 1500 1800 2100 2400 3 8 13 18 m/z t in min HPLC Mass Spectrometry  successfull detection and characterization 7

  8. Design of mdnA Libraries wt aa Y G G T F K Y P S D W E D Y modified tht gvt gvt ACC nkk AAA TAC CCT TCT GAC TGG GAA GAT tht Y G G F Y V A A A V aa diversity F D D … F W 10 diversity 5 0  Total Diversity: 810 possible mutants  • Library successfully generated 8

  9. The Progress Microcystis aeruginosa  mdn cluster  Library Generation Selection System Optimized Protease Inhibitor

  10. Phage Display coating binding washing elution infect E.coli 10

  11. Preparing the Phage microviridin gene III mdnA-myc-tag-geneIII mdnA-myc-geneIII mdnB mdnC mdnD mdnE M13 Phage myc-tag 11

  12. Establishing Phage Display Generated BioBricks mdnA-myc-gene III myc-gene III BBa_K627006 BBa_K627007 1,2 • myc tag detected 1 extinction at 492 nm  anti-geneVIII Ab-HRP 0,8 0,6 0,4 9E10 (anti-myc) Ab 0,2 0 control mdnA ELISA 12

  13. Test Panning 7 mdnA-Phage in % 6 5 4 3 2 1 0 pre-panning post panning Phage Display – Panning on Trypsin  • microviridin on phage 13

  14. Panning with Different Proteases 120 clone number after panning 100 80 60 40 20 0  • microvirdin binds papain 14

  15. The Progress Microcystis aeruginosa  mdn cluster  Library Generation  Selection System Optimized Protease Inhibitor

  16. In Vivo Selection • Basic Idea • β – lactamase is only active in periplasm • signal sequence of TorA serves as a export signal ssTorA ampicillin 16

  17. Results 140% R 120% P 100% Surviving CFU 80% BioBr 60% 40% 20% 0 0%  • functional export of β -lactamase into the periplasm worked  cells were able to survive up to 400 µg/ml ampicillin 17

  18. In Vivo Selection proteolytic cleavage • cells will die protease ampicillin 18

  19. Protease Detector at Work ? Generated BioBricks TorA-14 3C cleavage- β -lactamase TorA-TEV cleavage- β -lactamase BBa_K627012 BBa_K627013 AraC_14 3C TEV 14 3C AraC_TEV BBa_K627011 BBa_K627017 BBa_K627008 BBa_K627016 120 100 Surviving colonies (%) 80 60 • 40 Kill switch worked  20 0 0 0 0 0 0 0 0 0 25 50 75 100 150 200 300 400 600 800 Ampicillin concentration in µg/ml TorA-TEV cleavage- β -lactamase TorA-TEV cleavage- β -lactamase AraC_TEV 19

  20. In Vivo Selection INHIBITION TorA ampicillin 20

  21. Modeling of in vivo Selection can be modeled… 21

  22. Fitting the Model to Data  Model fitted to data 22

  23. The Progress Microcystis aeruginosa  mdn cluster  Library Generation   Selection System Optimized Protease Inhibitor

  24. Let‘s test the Libary - Results + mdnA libary Cells survive up to 400 µg/ml ampcillin  libary works 24

  25. The Progress Microcystis aeruginosa  mdn cluster  Library Generation   Selection System  Optimized Protease Inhibitor

  26. Human Practice and Xtras 26

  27. Parliament Survey Synthetic Biology: Medicine and Healthcare POTENTIAL RISK Asked: >600 Answers: 10  Invitation to German Parliament high medium low abstention high medium 27

  28. Visit the German Consulate Boston, 4th November 2011 All German finalist iGEM-teams at the German Consulate in Boston (Bielefeld, Munich and Potsdam ) 28

  29. Achievments and Future Plans • achievments: – 13 BioBricks • 5 for mdn modularization • 2 for phage display • 6 for in vivo selection – proof of principle for all systems – talk with German parliamentarian • future plans: – using the libary against different proteases – inhibition studies for new Microviridins 29

  30. Achievments and Future Plans … and another big achievment: The BioLog App 30

  31. A(pp)tention Please … 31

  32. Thank you for your attention! Dank: Instruktoren und Sponsore Refrences 32

  33. Questions? iGEM 2011 World Championship Jamboree at MIT in Boston Sunday, 6th November 2011

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend